Susan L. Slager

24.8k total citations · 1 hit paper
327 papers, 9.7k citations indexed

About

Susan L. Slager is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Susan L. Slager has authored 327 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Genetics, 167 papers in Pathology and Forensic Medicine and 72 papers in Immunology. Recurrent topics in Susan L. Slager's work include Chronic Lymphocytic Leukemia Research (173 papers), Lymphoma Diagnosis and Treatment (155 papers) and Immunodeficiency and Autoimmune Disorders (47 papers). Susan L. Slager is often cited by papers focused on Chronic Lymphocytic Leukemia Research (173 papers), Lymphoma Diagnosis and Treatment (155 papers) and Immunodeficiency and Autoimmune Disorders (47 papers). Susan L. Slager collaborates with scholars based in United States, France and Netherlands. Susan L. Slager's co-authors include James R. Cerhan, Neil E. Kay, Timothy G. Call, Tait D. Shanafelt, Steven P. Hamilton, Patrick J. McGrath, Susan M. Schwager, Thomas M. Habermann, Daniel J. Schaid and Clive S. Zent and has published in prestigious journals such as Nature Genetics, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Susan L. Slager

309 papers receiving 9.5k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II Gene

2000 861 citations Susan L. Slager et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan L. Slager United States	54	3.8k	3.3k	2.0k	1.9k	1.9k	327	9.7k
Antonio Uccelli Italy	58	3.4k 0.9×	7.5k 2.2×	2.1k 1.0×	4.2k 2.3×	3.8k 2.1×	236	16.7k
Mark Lathrop France	58	1.1k 0.3×	864 0.3×	918 0.5×	5.8k 3.1×	1.9k 1.0×	207	14.0k
Shereen Ezzat Canada	67	1.1k 0.3×	1.8k 0.5×	2.5k 1.2×	4.2k 2.3×	532 0.3×	317	16.4k
Gaetano Lombardi Italy	86	1.2k 0.3×	983 0.3×	976 0.5×	3.1k 1.6×	394 0.2×	445	24.2k
Patricia Ducy United States	42	1.7k 0.4×	1.1k 0.3×	4.7k 2.3×	11.3k 6.1×	638 0.3×	68	21.4k
Louis V. Avioli United States	59	2.2k 0.6×	720 0.2×	2.7k 1.3×	4.5k 2.4×	541 0.3×	273	12.6k
Michael P. Whyte United States	70	2.2k 0.6×	698 0.2×	3.7k 1.8×	6.0k 3.2×	361 0.2×	330	17.0k
Stavros C. Manolagas United States	76	2.4k 0.6×	1.1k 0.3×	8.3k 4.1×	14.1k 7.6×	1.8k 1.0×	140	23.0k
Makoto Kuro‐o Japan	83	3.4k 0.9×	541 0.2×	1.4k 0.7×	9.4k 5.0×	1.1k 0.6×	264	27.3k
David Goltzman Canada	82	3.8k 1.0×	459 0.1×	6.9k 3.4×	8.8k 4.7×	658 0.4×	410	21.0k

Countries citing papers authored by Susan L. Slager

Since Specialization

Citations

This map shows the geographic impact of Susan L. Slager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan L. Slager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan L. Slager more than expected).

Fields of papers citing papers by Susan L. Slager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan L. Slager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan L. Slager. The network helps show where Susan L. Slager may publish in the future.

Co-authorship network of co-authors of Susan L. Slager

This figure shows the co-authorship network connecting the top 25 collaborators of Susan L. Slager. A scholar is included among the top collaborators of Susan L. Slager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan L. Slager. Susan L. Slager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Qianqian, Yuan Gao, Sutapa Sinha, et al.. (2024). Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemia. SHILAP Revista de lepidopterología. 2(1). 100059–100059.

Tsang, Mazie, Paul J. Hampel, Kari G. Rabe, et al.. (2023). A study of frontline therapy in adults >80 years with chronic lymphocytic leukemia (CLL).. Journal of Clinical Oncology. 41(16_suppl). 12057–12057.

Boyle, Terry, Geffen Kleinstern, Paige M. Bracci, et al.. (2022). Physical activity and the risk of non‐Hodgkin lymphoma subtypes: A pooled analysis. International Journal of Cancer. 152(3). 396–407. 3 indexed citations

Eckel‐Passow, Jeanette E., Daniel H. Lachance, Paul A. Decker, et al.. (2022). Inherited genetics of adult diffuse glioma and polygenic risk scores—a review. Neuro-Oncology Practice. 9(4). 259–270. 3 indexed citations

Castellino, Alessia, Yucai Wang, Melissa C. Larson, et al.. (2021). Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes. Blood Advances. 6(4). 1350–1360. 13 indexed citations

Besson, Caroline, Amy Moore, Wenting Wu, et al.. (2021). Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer. International Journal of Epidemiology. 50(4). 1325–1334. 5 indexed citations

Boddicker, Nicholas, Melissa C. Larson, Alessia Castellino, et al.. (2021). Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era. American Journal of Hematology. 96(8). 979–988. 10 indexed citations

Parikh, Sameer A., Sara J. Achenbach, Timothy G. Call, et al.. (2020). The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice. Cancer Medicine. 9(10). 3390–3399. 39 indexed citations

Yan, Huihuang, Shulan Tian, Geffen Kleinstern, et al.. (2020). Chronic lymphocytic leukemia (CLL) risk is mediated by multiple enhancer variants within CLL risk loci. Human Molecular Genetics. 29(16). 2761–2774. 5 indexed citations

10.

Wang, Yucai, Matthew J. Maurer, Melissa C. Larson, et al.. (2019). Impact of metformin use on the outcomes of newly diagnosed diffuse large B‐cell lymphoma and follicular lymphoma. British Journal of Haematology. 186(6). 820–828. 17 indexed citations

11.

Tracy, Sean, Melissa C. Larson, Andrew L. Feldman, et al.. (2019). The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non‐follicular indolent B‐cell lymphomas. American Journal of Hematology. 94(6). 658–666. 13 indexed citations

12.

Wang, Yucai, Brian K. Link, Thomas E. Witzig, et al.. (2019). Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma. Blood. 134(16). 1289–1297. 20 indexed citations

13.

Famà, Angelo, Jinhua Xiang, Brian K. Link, et al.. (2018). Human Pegivirus infection and lymphoma risk and prognosis: a North American study. British Journal of Haematology. 182(5). 644–653. 20 indexed citations

14.

Slager, Susan L., Sara J. Achenbach, Yan W. Asmann, et al.. (2013). Mapping of the IRF8 Gene Identifies a 3′UTR Variant Associated with Risk of Chronic Lymphocytic Leukemia but not Other Common Non-Hodgkin Lymphoma Subtypes. Cancer Epidemiology Biomarkers & Prevention. 22(3). 461–466. 12 indexed citations

15.

Kelly, Jennifer L., Matthew T. Drake, Zachary S. Fredericksen, et al.. (2012). Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma. Cancer Causes & Control. 23(7). 1017–1029. 35 indexed citations

16.

Limsui, David, Robert A. Vierkant, Lori S. Tillmans, et al.. (2011). Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women. Gut. 61(9). 1299–1305. 32 indexed citations

17.

Kelly, Jennifer L., Anne J. Novak, Zachary S. Fredericksen, et al.. (2010). Germline Variation in Apoptosis Pathway Genes and Risk of Non–Hodgkin's Lymphoma. Cancer Epidemiology Biomarkers & Prevention. 19(11). 2847–2858. 34 indexed citations

18.

Shanafelt, Tait D., Matthew T. Drake, Matthew J. Maurer, et al.. (2010). Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood. 117(5). 1492–1498. 104 indexed citations

19.

Nowakowski, Grzegorz S., Matthew J. Maurer, Thomas M. Habermann, et al.. (2009). Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era. Journal of Clinical Oncology. 28(3). 412–417. 45 indexed citations

20.

Levy, Barcey T., George Bergus, Steven M. Levy, Susan L. Slager, & Mary C. Kiritsy. (1996). Longitudinal feeding patterns of infants. 2(1). 25–34. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact